Antidepressants
Published research on Antidepressants.
A recent publication in the Journal of Psychiatric Practice documented that nearly 4/5 individuals diagnosed with major depression are considered ineligible to participate in clinical trials…
Read article →We’ve all heard the media-driven dogma that everyone needs at least 8 hours of sleep per night for optimal neurophysiological performance. Striving for 8 hours of sleep is generally a health…
Read article →Neurofeedback is a technique that involves training an individual to consciously alter the electrical activity (brain waves) within their brain. The technique can be used as an intervention …
Read article →Those with social anxiety disorder are reported to suffer from debilitating, uncontrollable anxiety in social situations. This condition, also known as “social phobia” can lead to an intense…
Read article →Vyvanse (Lisdexamfetamine) is a drug developed by Shire Pharmaceuticals as a successor to Adderall. Vyvanse was first approved for the treatment of attention-deficit/hyperactivity disorder (…
Read article →Provigil (Modafinil) is a eugeroic drug that was originally approved in 1998 for the treatment of excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obst…
Read article →Trazodone (Desyrel) is classified as an atypical antidepressant, functioning specifically as an SARI (serotonin antagonist and reuptake inhibitor). It is considered a second generation antid…
Read article →